2glq
From Proteopedia
(New page: 200px<br /> <applet load="2glq" size="450" color="white" frame="true" align="right" spinBox="true" caption="2glq, resolution 1.60Å" /> '''X-ray structure of ...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2glq.gif|left|200px]]<br /> | + | [[Image:2glq.gif|left|200px]]<br /><applet load="2glq" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="2glq" size=" | + | |
caption="2glq, resolution 1.60Å" /> | caption="2glq, resolution 1.60Å" /> | ||
'''X-ray structure of human alkaline phosphatase in complex with strontium'''<br /> | '''X-ray structure of human alkaline phosphatase in complex with strontium'''<br /> | ||
==Overview== | ==Overview== | ||
| - | Strontium is used in the treatment of osteoporosis as a ranelate compound, and in the treatment of painful scattered bone metastases as isotope. At | + | Strontium is used in the treatment of osteoporosis as a ranelate compound, and in the treatment of painful scattered bone metastases as isotope. At very high doses and in certain conditions, it can lead to osteomalacia characterized by impairment of bone mineralization. The osteomalacia symptoms resemble those of hypophosphatasia, a rare inherited disorder associated with mutations in the gene encoding for tissue-nonspecific alkaline phosphatase (TNAP). Human alkaline phosphatases have four metal binding sites--two for zinc, one for magnesium, and one for calcium ion--that can be substituted by strontium. Here we present the crystal structure of strontium-substituted human placental alkaline phosphatase (PLAP), a related isozyme of TNAP, in which such replacement can have important physiological implications. The structure shows that strontium substitutes the calcium ion with concomitant modification of the metal coordination. The use of the flexible and polarizable force-field TCPEp (topological and classical polarization effects for proteins) predicts that calcium or strontium has similar interaction energies at the calcium-binding site of PLAP. Since calcium helps stabilize a large area that includes loops 210-228 and 250-297, its substitution by strontium could affect the stability of this region. Energy calculations suggest that only at high doses of strontium, comparable to those found for calcium, can strontium substitute for calcium. Since osteomalacia is observed after ingestion of high doses of strontium, alkaline phosphatase is likely to be one of the targets of strontium, and thus this enzyme might be involved in this disease. |
==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
| - | 2GLQ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NAG, PO3, ZN, MG and SR as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Alkaline_phosphatase Alkaline phosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.1 3.1.3.1] Full crystallographic information is available from [http:// | + | 2GLQ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=PO3:'>PO3</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=MG:'>MG</scene> and <scene name='pdbligand=SR:'>SR</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Alkaline_phosphatase Alkaline phosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.1 3.1.3.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GLQ OCA]. |
==Reference== | ==Reference== | ||
| Line 18: | Line 17: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
| - | [[Category: Du, M | + | [[Category: Du, M H.Le.]] |
[[Category: Llinas, P.]] | [[Category: Llinas, P.]] | ||
[[Category: Masella, M.]] | [[Category: Masella, M.]] | ||
[[Category: Menez, A.]] | [[Category: Menez, A.]] | ||
[[Category: Stigbrand, T.]] | [[Category: Stigbrand, T.]] | ||
| - | [[Category: Stura, E | + | [[Category: Stura, E A.]] |
[[Category: MG]] | [[Category: MG]] | ||
[[Category: NAG]] | [[Category: NAG]] | ||
| Line 33: | Line 32: | ||
[[Category: structure-function]] | [[Category: structure-function]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:32:55 2008'' |
Revision as of 15:32, 21 February 2008
|
X-ray structure of human alkaline phosphatase in complex with strontium
Contents |
Overview
Strontium is used in the treatment of osteoporosis as a ranelate compound, and in the treatment of painful scattered bone metastases as isotope. At very high doses and in certain conditions, it can lead to osteomalacia characterized by impairment of bone mineralization. The osteomalacia symptoms resemble those of hypophosphatasia, a rare inherited disorder associated with mutations in the gene encoding for tissue-nonspecific alkaline phosphatase (TNAP). Human alkaline phosphatases have four metal binding sites--two for zinc, one for magnesium, and one for calcium ion--that can be substituted by strontium. Here we present the crystal structure of strontium-substituted human placental alkaline phosphatase (PLAP), a related isozyme of TNAP, in which such replacement can have important physiological implications. The structure shows that strontium substitutes the calcium ion with concomitant modification of the metal coordination. The use of the flexible and polarizable force-field TCPEp (topological and classical polarization effects for proteins) predicts that calcium or strontium has similar interaction energies at the calcium-binding site of PLAP. Since calcium helps stabilize a large area that includes loops 210-228 and 250-297, its substitution by strontium could affect the stability of this region. Energy calculations suggest that only at high doses of strontium, comparable to those found for calcium, can strontium substitute for calcium. Since osteomalacia is observed after ingestion of high doses of strontium, alkaline phosphatase is likely to be one of the targets of strontium, and thus this enzyme might be involved in this disease.
Disease
Known disease associated with this structure: Osteoarthritis, susceptibility to OMIM:[608135]
About this Structure
2GLQ is a Single protein structure of sequence from Homo sapiens with , , , and as ligands. Active as Alkaline phosphatase, with EC number 3.1.3.1 Full crystallographic information is available from OCA.
Reference
Structural studies of human alkaline phosphatase in complex with strontium: implication for its secondary effect in bones., Llinas P, Masella M, Stigbrand T, Menez A, Stura EA, Le Du MH, Protein Sci. 2006 Jul;15(7):1691-700. PMID:16815919
Page seeded by OCA on Thu Feb 21 17:32:55 2008
Categories: Alkaline phosphatase | Homo sapiens | Single protein | Du, M H.Le. | Llinas, P. | Masella, M. | Menez, A. | Stigbrand, T. | Stura, E A. | MG | NAG | PO3 | SR | ZN | Strontium | Structure-function
